Management of HCC during COVID-19: ILCA guidance

Management of HCC during COVID-19: ILCA guidance

ILCA developed a guidance document on recommendations for the management of patients with liver cancer in the COVID-19 pandemic. This guidance document has been put together with the help and knowledge of ILCA Education Committee and Executive Committee.

Management of HCC during COVID-19: ILCA guidance – PDF

Management of HCC during COVID-19: ILCA guidance